Autopsy report · NCT04259684

Nitric Oxide During Cardiopulmonary Bypass in Neonates to Reduce Risk of Acute Kidney Injury

“revised and combined with another protocol”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2, Phase 3

Sponsor

Children's Hospital Medical Center, Cincinnati

Sponsor type

University, hospital or other

Conditions

Acute Kidney Injury; Congenital Heart Disease

Interventions

gases Nitric Oxide (gNO)

Participants

0

Trials that died the same way

• Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
  “Replaced by another protocol” (81% match in meaning)
• Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
  “study revised and reinitiated under another protocol” (79% match in meaning)
• RCT for Women With a Persisting Pregnancy of Unknown Location
  “A new protocol was written to replace this protocol.” (76% match in meaning)
• Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection
  “to be replaced with a different protocol” (75% match in meaning)
• Bacteriophage Therapy in Patients With Prosthetic Joint Infections
  “Changes to protocol design” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.